Wholly owned by the state-run large-scaled Red Sun Group Corporation, Jiangsu Zhongbang Pharmacy Co., Ltd. has a total investment of RMB200 million, and takes up a land of 200,000 m2. It is a hi-tech enterprise mainly developing and producing L-ephedrine serial products, heart and brain blood vessel disease, infection, respiration system, metabolism and incretion. With the technology base of Nanjing Red Sun Engineering Technology Center and Nanjing Red Sun Biological Pharmacy Engineering Technology Center, the company cooperates with other strong parties as China Pharmacy University, Dalian Institute of Physics and Chemistry, Jiangsu Province Institute of Material and Medicament and Metoblex Company in USA. It constantly promotes the strength in the raw material synthesizing pyridine ramification, R&D of new medicine, and innovation of formulations. Meanwhile the company carries out end-reaching sales business of medicines with the support of the strong medicine operating network, sales foundation, and clinical teams of Jiangsu Haibang Pharmacy Co., Ltd.
商铺手机链接：http://m.vooec.com/c_xhxing1102.html
商铺网站链接：http://xhxing1102.cn.vooec.com
主营业务：制剂 原料药